) Proportion of eligible patients = 18 years of age, who were prescribed aspirin, P2Y12 inhibitor, and statin at discharge following PCI with or without stenting.
-
-
1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.20 Testing Data Sources
-
1.14 Numerator
Patients who receive all medications for which they are eligible.
1. Aspirin prescribed at discharge (if eligible for aspirin as described in denominator)
AND
2. P2Y12 agent (clopidogrel, prasurgel, ticlopidine, or ticagrelor) prescribed at discharge (if eligible for P2Y12 as described in denominator)
AND
3. Statin prescribed at discharge (if eligible for statin as described in denominator)
-
1.15 Denominator
Patients surviving hospitalization who are eligible to receive any of the three medication classes:
1) Eligible for aspirin (ASA): Patients undergoing PCI who do not have a contraindication to aspirin documented
AND
2) Eligible for P2Y12 agent (clopidogrel, prasugrel, ticlopidine, or ticagrelor): Patients undergoing PCI with stenting who do not have a contraindication to P2Y12 agent documented
AND
3) Eligible for statin therapy: Patients undergoing PCI who do not have a contraindication to statin therapy.
-
Exclusions
The exclusions for this measure are comprised of patients without the following: (1) a PCI during the admission , (2)discharge status of deceased (9040), and (3) discharge location of “other acute hospital, hospice, or against medical advice.
-
OLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityEndorsed Cardiovascular Fall Cycle 2018Initial EndorsementLast Updated
-
StewardSteward Organization Email
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
Planned Use